Comparison of Characteristics and Significance of Immediate Versus Early Versus No Recurrence of Atrial Fibrillation After Catheter Ablation

American Journal of Cardiology

Volumn 103, Issue 9, 2009, Pages 1249-1254

  Koyama, Takashi ^a   Sekiguchi, Yukio ^a   Tada, Hiroshi ^a   Arimoto, Takanori ^a   Yamasaki, Hiro ^a   Kuroki, Kenji ^a   Machino, Takeshi ^a   Tajiri, Kazuko ^a   Zhu, Xu Dong ^a   Kanemoto, Miyako ^a   Sugiyasu, Aiko ^a   Kuga, Keisuke ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY TEMPERATURE; CARDIAC PATIENT; CATHETER ABLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PERICARDITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SUPRAVENTRICULAR PREMATURE BEAT; TREATMENT OUTCOME; VEIN SURGERY;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 65249145351     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.010     Document Type: Article

References (23)

1. Engelmann M.D., and Svendsen J.H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005) 2083-2092
2. Issac T.T., Dokainish H., and Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50 (2007) 2021-2028
3. Lellouche N., Jaïs P., Nault I., Wright M., Bevilacqua M., Knecht S., Matsuo S., Lim K.T., Sacher F., Deplagne A., et al. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol 19 (2008) 599-605
4. Lee S.H., Tai C.T., Hsieh M.H., Tsai C.F., Lin Y.K., Tsao H.M., Yu W.C., Huang J.L., Ueng K.C., Cheng J.J., Ding Y.A., and Chen S.A. Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol 10 (2004) 221-226
5. Hachiya H., Hirao K., Takahashi A., Nagata Y., Suzuki K., Maeda S., Sasaki T., Kawabata M., Isobe M., and Iesaka Y. Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation. J Cardiovasc Electrophysiol 18 (2007) 392-398
6. Hakala T., Pitkänen O., and Hippeläinen M. Feasibility of predicting the risk of atrial fibrillation after coronary artery bypass surgery with logistic regression model. Scand J Surg 91 (2002) 339-344
7. Lahtinen J., Biancari F., Salmela E., Mosorin M., Satta J., Rainio P., Rimpiläinen J., Lepojäivi M., and Juvonen T. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 77 (2004) 1241-1244
8. Suleiman M., Boulos M., and Hammerman H. Elevated levels of C-reactive protein are associated with new onset atrial fibrillation in patients with acute myocardial infarction. (abstract). Eur Heart J 27 suppl (2006) 44
9. Patane S., Saviolo R., and Patane F. Inflammation, atrial fibrillation, and acute myocardial infarction. (abstract). Eur Heart J 27 suppl (2006) 44
10. Madrid A.H. C-reactive protein and atrial fibrillation. An old marker looking for a new target. Rev Esp Cardiol 59 (2006) 94-98
11. Tieleman R.G., Van Gelder I.C., Crijns H.J., De Kam P.J., Van Den Berg M.P., Haaksma J., Van Der Woude H.J., and Allessie M.A. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?. J Am Coll Cardiol 31 (1998) 167-173
12. Halonen J., Halonen P., Järvinen O., Taskinen P., Auvinen T., Tarkka M., Hippeläinen M., Juvonen T., Hartikainen J., and Hakara T. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 297 (2007) 1562-1567
13. Rizos I., Tsiodras S., Rigopoulos A.G., Dragomanovits S., Kalogeropoulos A.S., Papathanasiou S., Sakadakis E.A., and Kremastinos D.T. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. Cytokine 40 (2007) 157-164
14. Fujiki A., Sakamoto T., Nishida K., Mizumaki K., and Inoue H. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation. J Cardiovasc Pharmacol 50 (2007) 264-266
15. Lee S.H., Chen Y.C., Chen Y.J., Chang S.L., Tai C.T., Wongcharoen W., Yeh H.I., Lin C.I., and Chen S.A. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 80 (2007) 1806-1815
16. Richter B., Gwechenberger M., Socas A., Marx M., and Gössinger H.D. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome. Am J Cardiol 101 (2008) 843-847
17. Nanthakumar K., Plumb V.J., Epstein A.E., Veenhuyzen G.D., Link D., and Kay G.N. Resumption of electrical conduction in previously isolated pulmonary veins: rationale for a different strategy?. Circulation 109 (2004) 1226-1229
18. Nilsson B., Chen X., Pehrson S., Køber L., Hilden J., and Svendsen J.H. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy. Am Heart J 152 suppl (2006) e1-e8 537
19. Ouyang F., Antz M., Ernst S., Hachiya H., Mavrakis H., Deger F.T., Schaumann A., Chun J., Falk P., Hennig D., et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111 (2005) 127-135
20. Pappone C., Santinelli V., Manguso F., Vicedomini G., Gugliotta F., Augeool G., Mazzone P., Tortoriello V., Landoni G., Zangrillo A., et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109 (2004) 327-334
21. Lo L.W., Tai C.T., Lin Y.J., Chang S.L., Wongcharoen W., Hsieh M.H., Tuan T.C., Udyavar A.R., Hu Y.F., Chen Y.J., Tsao H.M., and Chen S.A. Mechanisms of recurrent atrial fibrillation: comparisons between segmental ostial versus circumferential pulmonary vein isolation. J Cardiovasc Electrophysiol 18 (2007) 803-807
22. Oral H., Knight B.P., Ozaydin M., Tada H., Chugh A., Hassan S., Scharf C., Lai S.W., Greenstein R., Pelosi Jr. F., Strickberger S.A., and Morady F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 40 (2002) 100-104
23. Stein A., Wessling G., Deisenhofer I., Busch G., Steppich B., Estner H., Zrenner B., Schmitt C., Braun S., Schömig A., and Ott I. Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. Europace 10 (2008) 444-449